Vol.

No.

July 05, 2019Jul 05, 2019

DOWNLOAD THE PDF

Cover Story

It's time to rethink peer review policies—and consider an “Earth Shot Program”

At a recent NIH study section that I chaired, we had many applications that we reviewed as a group before the meeting. At the meeting, we were required to discuss over 50% of the grants.

Another Moonshot?
HHS should create an independent agency to manage cancer control in the U.S., NASEM recommends

By Claire Dietz and Matthew Bin Han Ong

Conversation with The Cancer Letter

NASEM: America needs a centralized National Cancer Control Plan

By Matthew Bin Han Ong and Claire Dietz

In Brief

UCI researchers to lead national effort to build atlas of human breast cells

Larry Kwak, Tanya Siddiqi named to new posts at City of Hope

Lawrence Boise named associate director for education and training at Winship Cancer Institute

Steven Dubinett honored at American Lung Association Gala

Funding Opportunities

DoD Melanoma Research Program Funding Opportunities for FY2019

Clinical Roundup

Cancer cost $94.4 billion in lost earnings and 8.7 million years of life in 2015

Noninvasive test improves detection of aggressive prostate cancer

Drugs & Targets

FDA approves Xpovio for refractory multiple myeloma

FDA approves Zirabev, a biosimilar to Avastin

European Commission approves Libtayo for advanced cutaneous squamous cell carcinoma

NCI Trials

NCI Trials for July

The National Cancer Institute Cancer Therapy Evaluation Program approved the following clinical research studies last month.

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues